(Q34277168)

English

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

based on heuristic

inferred from title

substance abuse

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Anne Lingford-Hughes

1

object named as

A R Lingford-Hughes

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

S Welch

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

L Peters

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

D J Nutt

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

British Association for Psychopharmacology, Expert Reviewers Group

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

23 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

899-952

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient: a case report.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Prediction of 7 months methadone maintenance treatment response by four measures of antisociality

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Methadone at tapered doses for the management of opioid withdrawal

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Dopamine agonists for the treatment of cocaine dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Benzodiazepines for alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment options for sleep disturbances during alcohol recovery

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Disulfiram effects on responses to intravenous cocaine administration

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comparing topiramate with naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Relapse prevention and maintaining abstinence in older adults with alcohol-use disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Monitored naltrexone without counseling for alcohol abuse/dependence in schizophrenia-spectrum disorders.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Gamma-butyrolactone (GBL) dependence and withdrawal

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Aripiprazole in schizophrenia with cocaine dependence: a pilot study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effects of alcoholism typology on response to naltrexone in the COMBINE study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Social anxiety impacts willingness to participate in addiction treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Prevalence of personality disorder in alcohol and drug services and associated comorbidity

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Lithium and marijuana withdrawal

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

EFNS guideline on the diagnosis and management of alcohol-related seizures: report of an EFNS task force.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experiment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

What makes for an effective stop-smoking service?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Severity and treatment of alcohol withdrawal in elderly versus younger patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Quetiapine in bipolar disorder and cocaine dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Review of the validity and significance of cannabis withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Methadone in pregnancy: treatment retention and neonatal outcomes.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Nicotine receptor partial agonists for smoking cessation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Medications acting on the GABA system in the treatment of alcoholic patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Efficacy of Psychostimulant Drugs for Cocaine Dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Concurrent and predictive validity of antisocial personality disorder subtyping among substance abusers.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A neurobiological basis for substance abuse comorbidity in schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Safety issues concerning the use of disulfiram in treating alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Substitution therapy for alcoholism: time for a reappraisal?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Does acamprosate improve reduction of drinking as well as aiding abstinence?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Benzodiazepine treatment of anxiety or insomnia in substance abuse patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Critical review of liability for benzodiazepine abuse among alcoholics

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Mortality among opiate users: opioid maintenance therapy, age and causes of death

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Methadone and perinatal outcomes: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Psychosocial interventions for people with both severe mental illness and substance misuse

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants--but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Anti-social personality disorder and response to methadone maintenance treatment.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Benzodiazepine use among heroin users: baseline use, current use and clinical outcome

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Improving the management of opioid-dependent pregnancies

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A prospective, open-label trial of ondansetron in adolescents with alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone treatment of adolescent alcoholics: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Gamma-hydroxybutyrate detoxification by titration and tapering.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The role of topiramate and other anticonvulsants in the treatment of alcohol dependence: a clinical review

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Methadone trough levels in pregnancy

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Alcohol in the elderly

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Consequences of multiple withdrawals from alcohol

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Misuse of alcohol or drugs by elderly people

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Pharmacotherapy of methamphetamine addiction: an update

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Methadone maintenance at different dosages for opioid dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Pregnancy outcome in women who use opiates

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The treatment of substance abusers diagnosed with obsessive-compulsive disorder: an outcome study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The role of a prescription in anxiety medication use, abuse, and dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Heroin maintenance for chronic heroin-dependent individuals

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comparison of methadone and slow-release morphine maintenance in pregnant addicts.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Topiramate for the treatment of alcohol dependence: comparison with naltrexone.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Disulfiram for the treatment of alcoholism. An evaluation in 128 men.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment of benzodiazepine withdrawal symptoms with carbamazepine

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Facilitation of Benzodiazepine Discontinuation by Melatonin

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: a 1 year prospective study in an Israeli clinic.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A placebo controlled trial of bupropion for smoking cessation in schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Combination of olanzapine with opioid-agonists in the treatment of heroin-addicted patients affected by comorbid schizophrenia spectrum disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo‐controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Smoking cessation interventions for patients with depression: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

How stable is the risk curve between alcohol and all-cause mortality and what factors influence the shape? A precision-weighted hierarchical meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treatment Outcome Research Study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Gamma hydroxy butyrate abuse and dependency

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Global burden of disease in young people aged 10-24 years: a systematic analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Inappropriate drug prescribing in elderly people is common

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Buprenorphine for the management of opioid withdrawal

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Alpha 2 -adrenergic agonists for the management of opioid withdrawal

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Oral substitution treatment of injecting opioid users for prevention of HIV infection

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Predicting response to opiate antagonists and placebo in the treatment of pathological gambling

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Olanzapine and haloperidol in first episode psychosis: two-year data

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Tobacco cessation interventions for young people

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Baseline trajectories of drinking moderate acamprosate and naltrexone effects in the COMBINE study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

New insights into the efficacy of naltrexone based on trajectory-based reanalyses of two negative clinical trials

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Heroin-assisted treatment for opioid dependence: Randomised controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effects of heroin-assisted treatment on alcohol consumption: findings of the German randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Is heroin-assisted treatment effective for patients with no previous maintenance treatment? Results from a German randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Bupropion SR worsens mood during marijuana withdrawal in humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

History of depression and smoking cessation outcome: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effectiveness of over-the-counter nicotine replacement therapy: a qualitative review of nonrandomized trials

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Anxiolytics for smoking cessation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Antidepressants for smoking cessation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A postmarketing study of relative abuse liability of hypnotic sedative drugs

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Medication treatment of different types of alcoholism

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Topiramate for treating alcohol dependence: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Neonatal abstinence syndrome after methadone or buprenorphine exposure

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The Safety of Transdermal Nicotine as an Aid to Smoking Cessation in Patients with Cardiac Disease

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A pilot trial of topiramate for the treatment of cocaine dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Clozapine treatment in patients with prior substance abuse

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Substance use and schizophrenia: adverse correlates in the CATIE study sample.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Time to rehospitalization of clozapine versus risperidone in the naturalistic treatment of comorbid alcohol use disorder and schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effect of early and late compliance on the effectiveness of acamprosate in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The Korsakoff syndrome: clinical aspects, psychology and treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Follow-up of 180 Alcoholic Patients for up to 7 Years After Outpatient Treatment: Impact of Alcohol Deterrents on Outcome

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

QTc interval screening in methadone treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Targeted naltrexone for problem drinkers

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment of polydrug-using opiate dependents during withdrawal: towards a standardisation of treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Retention in naltrexone implant treatment for opioid dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Youth with substance abuse and comorbid mental health disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Addiction Medicine

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effectiveness and safety of baclofen in the treatment of alcohol dependent patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Delirium associated with baclofen withdrawal: a review of common presentations and management strategies

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Baclofen and gamma-hydroxybutyrate withdrawal

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

"Pharming": the abuse of prescription and over-the-counter drugs in teens

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Impact of alcohol detoxification on anxiety and depressive symptoms

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Agonist substitution--a treatment alternative for high-dose benzodiazepine-dependent patients?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

From research to the real world: buprenorphine in the decade of the Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Neuropharmacology of addiction and how it informs treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Baclofen for alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effects of repeated withdrawal from alcohol on recovery of cognitive impairment under abstinence and rate of relapse

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Extended naltrexone and broad spectrum treatment or motivational enhancement therapy.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Quetiapine for alcohol use and craving in bipolar disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treating comorbid substance use disorders in schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Interventions for promoting smoking cessation during pregnancy

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Rivastigmine in Wernicke-Korsakoff's syndrome: five patients with rivastigmine showed no more improvement than five patients without rivastigmine

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Nervous system adverse responses to topiramate in the treatment of neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

International update: new findings on promising medications.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Case histories in pharmaceutical risk management

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Outpatient benzodiazepine detoxification procedure for methadone patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Drug and alcohol referrals: are elderly substance abuse diagnoses and referrals being missed?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A placebo-controlled trial of buspirone for the treatment of marijuana dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Efficacy of buspirone in alcohol dependence: a review

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Acamprosate: recent findings and future research directions

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Controlled trial of prescribed heroin in the treatment of opioid addiction

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The effects of current subsyndromal psychiatric symptoms or past psychopathology on alcohol dependence treatment outcomes and acamprosate efficacy

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Management of alcohol withdrawal delirium. An evidence-based practice guideline

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Oral naltrexone maintenance treatment for opioid dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Maintenance treatments for opiate dependent adolescent

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Maintenance agonist treatments for opiate dependent pregnant women

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Anticonvulsants for alcohol withdrawal

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Predicting treatment response to naltrexone: the influence of craving and family history

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Normalizing effects of modafinil on sleep in chronic cocaine users

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Clinical predictors of outcome from an Australian pharmacological relapse prevention trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Disulfiram treatment for alcoholism in severe mental illness

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The association between naltrexone treatment and symptoms of depression in opioid-dependent patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Self-help smoking cessation interventions in pregnancy: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Opioid maintenance therapy suppresses alcohol intake in heroin addicts with alcohol dependence: preliminary results of an open randomized study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Acamprosate and its efficacy in treating alcohol dependent adolescents

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment of depression in patients with opiate dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and alcohol treatments?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Alcohol use disorders in elderly people--redefining an age old problem in old age

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Nicotine gum for pregnant smokers: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The effects of naltrexone on alcohol and cocaine use in dually addicted patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Strategies for discontinuing long-term benzodiazepine use: meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Diacetylmorphine versus methadone for the treatment of opioid addiction

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The Andalusian trial on heroin-assisted treatment: a 2 year follow-up

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Antidepressants for cocaine dependence and problematic cocaine use

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphon

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone and disulfiram in patients with alcohol dependence and current depression.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Outcomes of Co‐Morbid Alcoholic Men: A 1‐Year Follow‐Up

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comorbid anxiety disorders and baseline medication regimens predict clinical outcomes in individuals with co-occurring bipolar disorder and alcohol dependence: Results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone for the treatment of alcohol dependence among African Americans: results from the COMBINE Study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Pharmacotherapy for pregnant women with addictions

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Mortality in heroin-assisted treatment in Switzerland 1994-2000.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Levetiracetam for the treatment of alcohol withdrawal syndrome: a multicenter, prospective, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Efficacy and tolerability of naltrexone in the treatment of alcohol dependence: oral versus injectable delivery.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Acamprosate for alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Opioid antagonists for alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Imipramine and Buspirone in Patients With Panic Disorder Who Are Discontinuing Long-term Benzodiazepine Therapy

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

High-dose naltrexone therapy for cocaine-alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Buprenorphine and carbamazepine as a treatment for detoxification of opiate addicts with multiple drug misuse: a pilot study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A case of withdrawal from the GHB precursors gamma-butyrolactone and 1,4-butanediol

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment approaches for older problem drinkers

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Personality disorder and drug use: a review

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Clinical guidelines: developing guidelines

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Topiramate in the treatment of substance-related disorders: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment for amphetamine withdrawal

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Psychoactive drug abuse in older adults

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Pharmacological treatment of substance-abusing schizophrenic patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Pentobarbital for severe gamma-butyrolactone withdrawal

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Disulfiram enhances subjective effects of dextroamphetamine in humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Developmental neurobiology of cognitive control and motivational systems

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: results from an open clinical study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment for amphetamine dependence and abuse.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The effect of methadone maintenance treatment on alcohol consumption: a systematic review

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Nicotine replacement therapy for smoking cessation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Mortality and cause of death among 1705 illicit drug users: a 37 year follow up.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Contingent reinforcement for benzodiazepine-free urines: evaluation of a drug abuse treatment intervention

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comparison of buprenorphine and methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment of opioid-dependent adolescents and young adults with buprenorphine

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Reboxetine for the treatment of patients with Cocaine Dependence Disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Successful acamprosate treatment of alcohol dependence in schizophrenia.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Cocaine Abuse in Methadone Maintenance Patients Is Associated with Low Serum Methadone Concentrations

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Psychotherapeutic benefits of opioid agonist therapy

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

A complex relationship between co-occurring social anxiety and alcohol use disorders: what effect does treating social anxiety have on drinking?

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Alcohol-related brain damage: report from a Medical Council on Alcohol Symposium, June 2010.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Management strategies in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Interventions for smoking cessation and reduction in individuals with schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Disulfiram in severe alcoholism--an open controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Patients with addiction and personality disorder: Treatment outcomes and clinical implications

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Co-morbidity of personality disorders in individuals with substance use disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Antisocial alcoholic patients show as much improvement at 14-month follow-up as non-antisocial alcoholic patients.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Long-term effects of heroin-assisted treatment in Germany

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Feasibility of an exercise counseling intervention for depressed women smokers

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment of out-patients with complicated benzodiazepine dependence: comparison of two approaches

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Long-term outcome after benzodiazepine withdrawal treatment in subjects with complicated dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Role of maintenance treatment in opioid dependence

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Treatment of benzodiazepine dependence in methadone maintenance treatment patients: a comparison of two therapeutic modalities and the role of psychiatric comorbidity

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Outcome criteria in smoking cessation trials: proposal for a common standard.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Smoking cessation guidelines for health professionals: an update. Health Education Authority

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Placebo-controlled trial of cytisine for smoking cessation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The severity of alcohol withdrawal is not age dependent

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Acupuncture and related interventions for smoking cessation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Quality of life in patients receiving opioid maintenance therapy. A comparative study of slow-release morphine versus methadone treatment

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

The size and burden of mental disorders and other disorders of the brain in Europe 2010.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Changes to methadone clearance during pregnancy.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Chronic benzodiazepine use in general practice patients with depression: an evaluation of controlled treatment and taper-off: report on behalf of the Dutch Chronic Benzodiazepine Working Group

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Opioids, sleep, and sleep-disordered breathing

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Comparison of Naltrexone and Placebo in Treatment of Alcohol Dependence of Adolescents

1 reference

https://api.crossref.org/works/10.1177%2F0269881112444324

21 January 2018

Identifiers

10.1177/0269881112444324

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

release_fbqynltjjna7jjph3gppa2ag7u

1 reference

https://api.fatcat.wiki/v0/release/fbqynltjjna7jjph3gppa2ag7u

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34277168&oldid=1985137031"